Log in

NASDAQ:STAASTAAR Surgical Stock Price, Forecast & News

$61.62
+1.19 (+1.97 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$60.13
Now: $61.62
$62.25
50-Day Range
$37.86
MA: $45.93
$61.62
52-Week Range
$23.20
Now: $61.62
$62.25
Volume562,325 shs
Average Volume929,649 shs
Market Capitalization$2.80 billion
P/E Ratio228.23
Dividend YieldN/A
Beta1.68
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The company provides Visian implantable collamer lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers intraocular lenses (IOLs), including collamer material and silicone foldable IOLs, and nanoFLEX IOL that produces a clearer image, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision centers, surgical centers, hospitals, government facilities, and distributors primarily under the STAAR, EVO Visian ICL, Evolution in Visual Freedom, Visian, Collamer, CentraFLOW, AquaPORT, nanoFLEX, nanoPOINT, and Afinity trademarks. The company sells products directly through its sales representatives in the United States, Japan, Spain, Germany, Canada, the United Kingdom, and Singapore, as well as through independent distributors in China, Korea, India, and internationally. STAAR Surgical Company was founded in 1982 and is based in Monrovia, California.
Read More
STAAR Surgical logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.4Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.27 out of 5 stars


Industry, Sector and Symbol

Industry Ophthalmic goods
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:STAA
CUSIP85231230
Phone626-303-7902

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$150.18 million
Cash Flow$0.57 per share
Book Value$3.59 per share

Profitability

Net Income$14.05 million

Miscellaneous

Employees475
Market Cap$2.80 billion
Next Earnings Date7/29/2020 (Estimated)
OptionableOptionable

Receive STAA News and Ratings via Email

Sign-up to receive the latest news and ratings for STAA and its competitors with MarketBeat's FREE daily newsletter.

STAAR Surgical (NASDAQ:STAA) Frequently Asked Questions

How has STAAR Surgical's stock been impacted by COVID-19 (Coronavirus)?

STAAR Surgical's stock was trading at $28.01 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, STAA shares have increased by 120.0% and is now trading at $61.62. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of STAAR Surgical?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for STAAR Surgical in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for STAAR Surgical.

When is STAAR Surgical's next earnings date?

STAAR Surgical is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for STAAR Surgical.

How were STAAR Surgical's earnings last quarter?

STAAR Surgical (NASDAQ:STAA) issued its quarterly earnings data on Wednesday, May, 6th. The medical instruments supplier reported $0.04 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.03 by $0.01. The medical instruments supplier had revenue of $35.19 million for the quarter, compared to analyst estimates of $34.90 million. STAAR Surgical had a net margin of 8.21% and a return on equity of 12.52%. The company's revenue was up 8.0% compared to the same quarter last year. View STAAR Surgical's earnings history.

What guidance has STAAR Surgical issued on next quarter's earnings?

STAAR Surgical updated its first quarter 2020 Pre-Market earnings guidance on Monday, April, 13th. The company provided EPS guidance of for the period. The company issued revenue guidance of $34.9-34.9 million, compared to the consensus revenue estimate of $32.22 million.

What price target have analysts set for STAA?

4 analysts have issued 1 year price objectives for STAAR Surgical's shares. Their forecasts range from $37.00 to $55.00. On average, they expect STAAR Surgical's stock price to reach $44.25 in the next twelve months. This suggests that the stock has a possible downside of 28.2%. View analysts' price targets for STAAR Surgical.

Has STAAR Surgical been receiving favorable news coverage?

News articles about STAA stock have trended neutral this week, according to InfoTrie. InfoTrie rates the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. STAAR Surgical earned a media sentiment score of 0.5 on InfoTrie's scale. They also gave headlines about the medical instruments supplier a news buzz of 3.0 out of 10, meaning that recent news coverage is unlikely to have an impact on the company's share price in the near future. View the latest news about STAAR Surgical.

Who are some of STAAR Surgical's key competitors?

What other stocks do shareholders of STAAR Surgical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STAAR Surgical investors own include Crispr Therapeutics (CRSP), NVIDIA (NVDA), Sorrento Therapeutics (SRNE), Ring Energy (REI), Ring Energy (REI), Rockwell Medical (RMTI), Sangamo Therapeutics (SGMO), AbbVie (ABBV), Advanced Micro Devices (AMD) and Amarin (AMRN).

Who are STAAR Surgical's key executives?

STAAR Surgical's management team includes the following people:
  • Ms. Caren L. Mason, CEO, Pres & Director (Age 65)
  • Ms. Deborah J. Andrews, Chief Financial Officer (Age 62)
  • Dr. Keith Holliday, Chief Technology Officer (Age 56)
  • Mr. Samuel J. Gesten, Chief Legal Officer & Corp. Sec. (Age 57)
  • Mr. Hans-Martin Blickensdoerfer, Sr. VP of Commercial Operations, Direct Markets- Europe & China (Age 54)

What is STAAR Surgical's stock symbol?

STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA."

How do I buy shares of STAAR Surgical?

Shares of STAA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is STAAR Surgical's stock price today?

One share of STAA stock can currently be purchased for approximately $61.62.

How big of a company is STAAR Surgical?

STAAR Surgical has a market capitalization of $2.80 billion and generates $150.18 million in revenue each year. The medical instruments supplier earns $14.05 million in net income (profit) each year or $0.46 on an earnings per share basis. STAAR Surgical employs 475 workers across the globe.

What is STAAR Surgical's official website?

The official website for STAAR Surgical is www.staar.com.

How can I contact STAAR Surgical?

STAAR Surgical's mailing address is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. The medical instruments supplier can be reached via phone at 626-303-7902 or via email at [email protected]

This page was last updated on 7/5/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.